TEACHERS ADVISORS, LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 264 filers reported holding MYRIAD GENETICS INC in Q1 2019. The put-call ratio across all filers is 2.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q1 2019$5,109,000
+18.9%
153,896
+4.1%
0.01%0.0%
Q4 2018$4,298,000
-63.2%
147,864
-41.8%
0.01%
-14.3%
Q3 2018$11,680,000
+151.1%
253,896
+104.0%
0.01%
+16.7%
Q2 2018$4,651,000
+33.7%
124,458
+5.7%
0.01%
+20.0%
Q1 2018$3,478,000
-14.0%
117,6950.0%0.01%0.0%
Q4 2017$4,042,000
-3.5%
117,695
+1.7%
0.01%
-16.7%
Q3 2017$4,188,000
+40.4%
115,747
+0.3%
0.01%
+50.0%
Q2 2017$2,982,000
+32.8%
115,407
-1.3%
0.00%
+33.3%
Q1 2017$2,245,000
+16.4%
116,924
+1.1%
0.00%0.0%
Q4 2016$1,928,000
-15.3%
115,637
+4.6%
0.00%
-25.0%
Q3 2016$2,276,000
-32.7%
110,5860.0%0.00%
-33.3%
Q2 2016$3,384,000
-21.3%
110,586
-3.7%
0.01%
-25.0%
Q1 2016$4,300,000
-1.7%
114,875
+13.3%
0.01%0.0%
Q4 2015$4,375,000
+13.6%
101,366
-1.3%
0.01%0.0%
Q3 2015$3,850,000
+10.3%
102,7160.0%0.01%
+33.3%
Q2 2015$3,491,000
+87.4%
102,716
+95.2%
0.01%
+100.0%
Q1 2015$1,863,000
-1.3%
52,615
-5.0%
0.00%
-25.0%
Q4 2014$1,887,000
-0.4%
55,410
+12.8%
0.00%0.0%
Q3 2014$1,895,000
+0.8%
49,141
+1.7%
0.00%0.0%
Q2 2014$1,880,000
+0.7%
48,311
-11.5%
0.00%0.0%
Q1 2014$1,867,000
+53.7%
54,614
-5.7%
0.00%
+33.3%
Q4 2013$1,215,000
+8.7%
57,892
+21.7%
0.00%0.0%
Q3 2013$1,118,000
-12.6%
47,557
-0.1%
0.00%0.0%
Q2 2013$1,279,00047,5930.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$90,850,0003.94%
Altium Capital Management LP 221,000$4,016,0001.61%
DISCIPLINED GROWTH INVESTORS INC /MN 1,900,787$34,537,0000.93%
Zebra Capital Management LLC 15,352$279,0000.82%
PFM Health Sciences, LP 1,177,250$21,391,0000.82%
EARNEST PARTNERS LLC 6,462,138$117,417,0000.78%
Glenview Capital Management 1,696,791$30,831,0000.77%
AIMZ Investment Advisors, LLC 42,085$765,0000.37%
Phocas Financial Corp. 127,949$2,325,0000.35%
Redhawk Wealth Advisors, Inc. 34,680$630,0000.29%
View complete list of MYRIAD GENETICS INC shareholders